Single step deployment system increases market potential while reducing install times by 80% Incorporates Enhanced ContraPest Formulation for Improved Performance in the Field PHOENIX, July 24, 2023 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"),...
SenesTech (SNES) Fireside Chat
During this fireside chat, we welcome SenesTech, ticker symbol of SNES on the NASDAQ, and their CEO, Joel Fruendt. SenesTech is committed to improving the health of our world by humanely managing animal populations through fertility control. This Fireside Chat was...
SenesTech to Participate at Lytham Partners Spring 2023 Investor Conference on May 18, 2023
PHOENIX, May 15, 2023 -- SenesTech, Inc. (NASDAQ: SNES) (www.senestech.com) the rodent fertility control experts and inventors of the only EPA-registered contraceptive for male and female rats, ContraPest®, today announced Joel Fruendt, CEO, will participate in a...
SenesTech Announces First Quarter 2023 Financial Results
E-Commerce Leads Growth at 54% Year Over Year PHOENIX, May 11, 2023 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA-registered contraceptive for male and female...
SenesTech to Report First Quarter 2023 Financial Results on Thursday, May 11, 2023
Financial results to be released after market close; Conference call to be conducted at 5:00 pm ET PHOENIX, May 4, 2023 -- SenesTech, Inc. (NASDAQ: SNES) will report financial results for its first quarter 2023, ended March 31, 2023, after the market close on...
SenesTech and ContraPest® Featured at the Animal Care Expo in New Orleans
Growth in the Animal Care Segment of Pest Control Continues to Be Strong PHOENIX, April 11, 2023 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered...
TIME Magazine Takes a Closer Look at ContraPest as a Solution to Global Rat Infestations
PHOENIX, March 29, 2023 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, ContraPest®, were featured in TIME...
SenesTech Announces 2022 Financial Results
Product Sales Break $1 Million Sales Increase 77% for the Year PHOENIX, March 16, 2023 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA-registered contraceptive for...
ContraPest® Success Stories Reported at Vertebrate Pest Conference
PHOENIX, Feb. 28, 2023 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, ContraPest®, today announced that...
SenesTech Names Nicole Williams as Chief Revenue Officer
PHOENIX, Feb. 16, 2023 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, ContraPest®, today reported the...